Compounds > glucose, (beta-d)-isomer
Page last updated: 2024-08-24

glucose, (beta-d)-isomer and sirolimus

glucose, (beta-d)-isomer has been researched along with sirolimus in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Arita, M; Ohira, T; Omori, K; Recchiuti, A; Serhan, CN; Van Dyke, TE1
Esser, J; Gabrielsson, S; Gehrmann, U; Haeggström, JZ; Rådmark, O; Salvado, MD; Samuelsson, B; Scheynius, A; Wetterholm, A1
Guden, DS; Kocak, Z; Kucukkavruk, SP; Malik, KU; Sahan-Firat, S; Sari, AN; Temiz-Resitoglu, M; Tunctan, B1
Li, YZ; Tang, YJ; Wu, C; Yue, XJ; Zhang, L; Zhang, P1
Wang, L; Zhang, J; Zhu, J1

Other Studies

5 other study(ies) available for glucose, (beta-d)-isomer and sirolimus

ArticleYear
Resolvin E1 receptor activation signals phosphorylation and phagocytosis.
    The Journal of biological chemistry, 2010, Jan-29, Volume: 285, Issue:5

    Topics: Animals; Cell Differentiation; CHO Cells; Cricetinae; Cricetulus; Eicosapentaenoic Acid; Flavonoids; HL-60 Cells; Humans; Inflammation; Lipids; Macrophages; Phagocytosis; Phosphorylation; Receptors, Chemokine; Sirolimus; Zymosan

2010
Zymosan suppresses leukotriene C₄ synthase activity in differentiating monocytes: antagonism by aspirin and protein kinase inhibitors.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:4

    Topics: Aspirin; Cell Differentiation; Cell Line; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Glutathione Transferase; Humans; Leukotriene C4; Macrophages; Protein Kinase C; Protein Kinase Inhibitors; Receptors, Prostaglandin E; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Staurosporine; Toll-Like Receptor 2; Zymosan

2011
Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.
    Inflammation, 2018, Volume: 41, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arterial Pressure; Cyclooxygenase 2; Cytokines; Disease Models, Animal; I-kappa B Proteins; Inflammation; Inflammation Mediators; Male; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Nitrosative Stress; Oxidative Stress; Phosphorylation; Protein Kinase Inhibitors; Rats, Wistar; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases; Vasodilation; Zymosan

2018
Effects of glycosylation on the bioactivity of rapamycin.
    Applied microbiology and biotechnology, 2020, Volume: 104, Issue:21

    Topics: Glucosides; Glycosylation; Glycosyltransferases; Molecular Docking Simulation; Sirolimus

2020
Galuteolin Inhibited Autophagy for Neuroprotection Against Transient Focal Cerebral Ischemia in Rats.
    Neuromolecular medicine, 2020, Volume: 22, Issue:4

    Topics: Animals; Autophagy; Body Water; Cerebral Infarction; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucosides; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Luteolin; Male; Molecular Structure; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sirolimus

2020